BULLETIN
C-19 Vaccine Breakthrough
Important, Columnist Says
A story reported out by Reuters News Agency yesterday shows very promising results in the study of one of the leading COVID-19 vaccine candidates, AllOTSEGO's COVID columnist, Dr. Richard Sternberg, reports today.
The vaccine being developed by Oxford University and British Drug maker AstraZenica shows that it produces an immune response, i.e., development of antibodies to the virus, in both the young and the old. This is seen as a very favorable breakthrough in the development of vaccines.